Literature DB >> 12133897

The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells.

Zheng Xu1, David Stokoe, Lawrence P Kane, Arthur Weiss.   

Abstract

In this study, we characterize the function of the tumor suppressor gene PTEN in Jurkat T cells. We established stable clones of Jurkat T cells that inducibly express either wild-type or phosphatase-inactive PTEN. We show here that PTEN potently inhibited the growth and reduced the size of Jurkat cells. The growth-suppressive effect of PTEN was associated with its ability to induce apoptotic cell death with little or no effect on cell cycle. PTEN also rendered Jurkat cells more susceptible to apoptosis induced by various stimuli. Furthermore, PTEN expression led to a reduction in the level of 3'-phosphorylated phospholipids and thus altered the activity and localization of Akt. Finally, coexpression of constitutively active Akt reversed the effects caused by PTEN. In summary, our results suggest that PTEN suppresses cell growth, promotes apoptosis, and decreases cell size by negatively regulating the phosphoinositide 3-kinase/Akt pathway in Jurkat T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133897

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  25 in total

1.  Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN.

Authors:  Ping Gao; Ronald L Wange; Ning Zhang; Joost J Oppenheim; O M Zack Howard
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

2.  PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs.

Authors:  Patrick T Walsh; Jodi L Buckler; Jidong Zhang; Andrew E Gelman; Nicole M Dalton; Devon K Taylor; Steven J Bensinger; Wayne W Hancock; Laurence A Turka
Journal:  J Clin Invest       Date:  2006-08-17       Impact factor: 14.808

3.  Molecular mechanism of size control in development and human diseases.

Authors:  Xiaolong Yang; Tian Xu
Journal:  Cell Res       Date:  2011-04-12       Impact factor: 25.617

Review 4.  The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.

Authors:  Rui D Mendes; Kirsten Canté-Barrett; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2016-09       Impact factor: 9.941

5.  Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells.

Authors:  Malini Natarajan; Avery August; Andrew J Henderson
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

6.  Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL).

Authors:  Ryu-ichi Fukuda; Ayako Hayashi; Atae Utsunomiya; Yuko Nukada; Rie Fukui; Katsuhiko Itoh; Katsunari Tezuka; Kazumasa Ohashi; Kensaku Mizuno; Manabu Sakamoto; Masahiro Hamanoue; Takashi Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

7.  Rapid hepatocyte nuclear translocation of the Forkhead Box M1B (FoxM1B) transcription factor caused a transient increase in size of regenerating transgenic hepatocytes.

Authors:  Xinhe Wang; Dibyendu Bhattacharyya; Margaret B Dennewitz; Vladimir V Kalinichenko; Yan Zhou; Rita Lepe; Robert H Costa
Journal:  Gene Expr       Date:  2003

8.  Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.

Authors:  Teresa Palomero; Maria Luisa Sulis; Maria Cortina; Pedro J Real; Kelly Barnes; Maria Ciofani; Esther Caparros; Jean Buteau; Kristy Brown; Sherrie L Perkins; Govind Bhagat; Archana M Agarwal; Giuseppe Basso; Mireia Castillo; Satoru Nagase; Carlos Cordon-Cardo; Ramon Parsons; Juan Carlos Zúñiga-Pflücker; Maria Dominguez; Adolfo A Ferrando
Journal:  Nat Med       Date:  2007-09-16       Impact factor: 53.440

Review 9.  Feeding an army: The metabolism of T cells in activation, anergy, and exhaustion.

Authors:  Greg M Delgoffe; Jonathan D Powell
Journal:  Mol Immunol       Date:  2015-12       Impact factor: 4.407

10.  Missense mutation in the PTEN promoter of a patient with hemifacial hyperplasia.

Authors:  Kiyomi Yamazaki; Charis Eng; Sergei A Kuznetsov; John Reinisch; Dennis-Duke Yamashita; John Walker; Craig Cheung; Pamela G Robey; Stephen L-K Yen
Journal:  Bonekey Rep       Date:  2015-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.